IndiaTickerLatest filing: Copy of Newspaper Publication - BALAXI PHARMACEUTICALS LIMITED
ObservedCompany dossier
Balaxi Pharmaceuticals
NSE:BALAXI · ISIN INE618N01022
- Close
- ₹24.14 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Balaxi Pharmaceuticals
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Dec 2024 · revenue ₹73.3 Cr · PAT ₹5.4 Cr.
Exchange XBRLLatest ownership: promoter group 65.99% and public 34.01% as of 30 Jun 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing Copy of Newspaper Publication - BALAXI PHARMACEUTICALS LIMITED
NSE · exchange filing
Observed
Archived filing Reply to Clarification- Financial results - BALAXI PHARMACEUTICALS LIMITED
NSE · financial results
Observed
Source filing Updates - BALAXI PHARMACEUTICALS LIMITED
NSE · exchange filing
Observed
Source filing Certificate under SEBI (Depositories and Participants) Regulations, 2018 - BALAXI PHARMACEUTICALS LIMITED
NSE · exchange filing
Reported financials
Full financials →31 Dec 2024
- Revenue from operations
- ₹73.3 Cr
- Profit after tax
- ₹5.4 Cr
- EPS
- ₹0.97
Observed NSE structured filing · Consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 65.99%
- Public
- 34.01%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL